Correlation Between Larimar Therapeutics and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Larimar Therapeutics and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Alnylam Pharmaceuticals.
Diversification Opportunities for Larimar Therapeutics and Alnylam Pharmaceuticals
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Larimar and Alnylam is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 1.82 times more return on investment than Alnylam Pharmaceuticals. However, Larimar Therapeutics is 1.82 times more volatile than Alnylam Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about 0.07 per unit of risk. If you would invest 340.00 in Larimar Therapeutics on August 24, 2024 and sell it today you would earn a total of 273.00 from holding Larimar Therapeutics or generate 80.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Larimar Therapeutics vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Larimar Therapeutics |
| Alnylam Pharmaceuticals |
Larimar Therapeutics and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and Alnylam Pharmaceuticals
The main advantage of trading using opposite Larimar Therapeutics and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |